Decisions about add-on reimbursement for medical devices in France in December 2019

20

Jan 2020

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in December 2019.

Four (4) decisions were released for cardiovascular devices:

  • ANGIOLITE, coronary stent coated with sirolimus (pharmacologically active product) (application for registration, rejected because the provided data do not establish the interest)
  • ROTALINK PLUS, rotational atherectomy system (application for registration, approved)
  • ROTAPRO, rotational atherectomy system (application for registration, approved)
  • PORTICO, aortic heath valve (application for registration, approved)

One (1) decision was released for other devices:

  • FREESTYLE COMFORT, mobile oxygen concentrator (portable) (application for registration, approved)

See the news in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

Tags
France
Reimbursement
Cardiovascular devices
Medical aids

The latest related news

Rapid HTAs of five medical devices released in Tuscany

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

 Read more
2022 RIHN and Supplementary list for IVD tests published in France

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

 Read more
New procedure and diagnostic codes added to the private reimbursement schedule in England

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

 Read more
Assessments of monitoring and diagnostics of atrial fibrillation products released in Sweden

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

 Read more
Theme survey on products for monitoring and diagnostics of sepsis launched by Swedish TLV

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

 Read more